The biopharmaceutical company Lipum specializes in the discovery and development of novel drugs to treat diseases related to chronic inflammation. The company has developed its first candidate drug in collaboration … Continue reading Industry case: With support from two SciLifeLab service areas, Lipum AB develops a biomarker assay to support the development of a novel drug for chronic inflammation